Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-14

Clinical Trial Update: Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing low and high doses of prophylactic vitamin D for prevention of osteopenia of prematurity; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Alexandria University | Conditions: Osteopenia of Prematurity | Phase 2 | Status: COMPLETED